(Q43690269)

English

Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women

scientific article published in August 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

Genazzani AD

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Stomati M

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Strucchi C

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Puccetti S

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Luisi S

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Genazzani AR

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

241-248

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Relationship between serum dehydroepiandrosterone sulfate, androstenedione, and sex hormones in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Control of Adrenal Androgen Secretion*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Plasma dehydroepiandrosterone sulfate in normal and pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Difference of LH and FSH secretory characteristics and degree of concordance between postmenopausal and aging women.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Effects of Progestin-Opposed Transdermal Estrogen Administration on Growth Hormone and Insulin-Like Growth Factor-I in Postmenopausal Women of Different Ages*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2901902-1

7 January 2021

Identifiers

10.1016/S0015-0282(01)01902-1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43690269&oldid=2102602983"